Literature DB >> 31172516

Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.

Daniel J Czyzyk1, Margarita Valhondo2, William L Jorgensen2, Karen S Anderson1.   

Abstract

Thymidylate synthase (TS), found in all organisms, is an essential enzyme responsible for the de novo synthesis of deoxythymidine monophosphate. The TS active sites of the protozoal parasite Cryptosporidium hominis and human are relatively conserved. Evaluation of antifolate compound 1 and its R-enantiomer 2 against both enzymes reveals divergent inhibitor selectivity and enzyme stereospecificity. To establish how C. hominis and human TS (ChTS and hTS) selectively discriminate 1 and 2, respectively, we determined crystal structures of ChTS complexed with 2 and hTS complexed with 1 or 2. Coupled with the previously determined structure of ChTS complexed with 1, we discuss a possible mechanism for enzyme stereospecificity and inhibitor selectivity.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990Cryptosporidium hominiszzm321990; X-ray crystallography; chiral recognition; enzyme stereospecificity; inhibitor selectivity; thymidylate synthase

Mesh:

Substances:

Year:  2019        PMID: 31172516      PMCID: PMC6690774          DOI: 10.1002/1873-3468.13474

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

Review 1.  Three-dimensional view of pharmacology.

Authors:  I W Wainer
Journal:  Am J Hosp Pharm       Date:  1992-09

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  Biological chiral recognition: the substrate's perspective.

Authors:  Vidyasankar Sundaresan; Ravinder Abrol
Journal:  Chirality       Date:  2005       Impact factor: 2.437

Review 4.  A perspective on enzyme catalysis.

Authors:  Stephen J Benkovic; Sharon Hammes-Schiffer
Journal:  Science       Date:  2003-08-29       Impact factor: 47.728

5.  Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.

Authors:  R Almog; C A Waddling; F Maley; G F Maley; P Van Roey
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

6.  Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.

Authors:  P H Sayre; J S Finer-Moore; T A Fritz; D Biermann; S B Gates; W C MacKellar; V F Patel; R M Stroud
Journal:  J Mol Biol       Date:  2001-11-02       Impact factor: 5.469

7.  Pyrrolo[2,3-d]pyrimidine thymidylate synthase inhibitors: design and synthesis of one-carbon bridge derivatives.

Authors:  K Aso; Y Imai; K Yukishige; K Ootsu; H Akimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-10       Impact factor: 1.645

8.  Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase.

Authors:  Robert H O'Neil; Ryan H Lilien; Bruce R Donald; Robert M Stroud; Amy C Anderson
Journal:  J Biol Chem       Date:  2003-10-09       Impact factor: 5.157

9.  Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.

Authors:  Chloé E Atreya; Karen S Anderson
Journal:  J Biol Chem       Date:  2004-02-12       Impact factor: 5.157

10.  Solving structures of protein complexes by molecular replacement with Phaser.

Authors:  Airlie J McCoy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-12-13
View more
  2 in total

1.  Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.

Authors:  D J Czyzyk; M Valhondo; L Deiana; J Tirado-Rives; W L Jorgensen; K S Anderson
Journal:  Eur J Med Chem       Date:  2019-09-04       Impact factor: 6.514

2.  Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus.

Authors:  Siyu Wang; Stephanie M Reeve; Graham T Holt; Adegoke A Ojewole; Marcel S Frenkel; Pablo Gainza; Santosh Keshipeddy; Vance G Fowler; Dennis L Wright; Bruce R Donald
Journal:  PLoS Comput Biol       Date:  2022-02-10       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.